Menu

Another Andrew Wakefield Movie in the Works

This one will be largely based on the discredited anti-vaccine researcher’s 2010 book.

May 4, 2016
Bob Grant

YOUTUBE, THE WELLNESS WAY CLINICSIt looks like notorious anti-vaccine researcher Andrew Wakefield will make it onto the silver screen yet again. A month ago, the documentary he co-directed, Vaxxed, premiered in New York City. Now, a Hollywood screenwriter—with cowriting credits on blockbusters including Shrek and Pirates of the Caribbean—intends to write a film adaptation of Wakefield’s 2010 book Callous Disregard: Autism and Vaccines—The Truth Behind a Tragedy.

By all appearances, the new film will be a sympathetic look at the life and work of Wakefield, whose claims that measles, mumps, and rubella (MMR) vaccines cause autism have been thoroughly debunked by reams of scientific research. Wakefield himself was repudiated by publishers and the U.K.’s General Medical Council for violating ethical standards. Similarly, the claims Wakefield made in Callous Disregard have been disproven. “[The book] is just terrible,” Joel Harrison, a retired epidemiologist who wrote a point-by-point takedown of Wakefield’s book in a 2013 The Open Vaccine Journal article, told STAT News. “If he handed it in as a term paper as an undergraduate, I wouldn’t pass him.”

Terry Rossio, the screenwriter taking on the new Wakefield movie project, has indicated that the film will highlight the work and life of the controversial researcher. “Dr. Wakefield is clearly a polarizing figure, reviled by the general public yet also revered by many,” he told Variety. “The details and drama surrounding his life are even more remarkable than generally known.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!